Experiencenew
Branding & Naming Experience
Brand Institute excels as the global leader in brand name and identity development, spanning healthcare, consumer products, and pharmaceutical standards. With over 75% of drug name approvals globally and unparalleled success in consumer and business-to-business branding, it sets the industry benchmark. Additionally, it dominates USAN/INN naming, with significant majorities in drug name approvals worldwide.
1,456
Healthcare Clients
4,777
Total Healthcare Names
1,621
USAN/INN (Nonproprietary)
456
Consumer/B2B Clients
980
Total Consumer/B2B Names
94
Corporate Identities
General Search
Showing 1 - 10 out of 11
Brand | Client | Service | Category |
---|---|---|---|
Lunesta | Waylis Therapeutics | ||
Entyvio | Takeda | ||
Hemlibra | Genentech | ||
Brukinsa | BeiGene | ||
Imbruvica | Johnson & Johnson Johnson & Johnson Innovative Medicine | ||
Adcetris | Pfizer Seagen | ||
Cologuard | Exact Sciences | ||
CXCessor4 | Bristol Myers Squibb | ||
Xtandi | Astellas / Pfizer | ||
Avastin | Genentech |
1
2